Dr Elizabeth Barr

Research fellow

Qualifications:

PhD, Monash University, 2009; Master of Public Health, University of New South Wales, 2003; Graduate Diploma in Podiatry, La Trobe University, 1996; Bachelor of Podiatry, La Trobe University, 1993.

Location:

Melbourne

Biography:

Dr Elizabeth Barr is currently a National Health and Medical Research Council post-doctoral fellow and holds a research fellow position at the Menzies School of Health Research. Her research focuses on the contribution of hyperglycaemia, diabetes and related risk factors to premature mortality and cardiovascular disease, including the impact of ethnicity on these relationships. Her research expertise is in epidemiology, specifically survival analyses, data linkage, follow-up of large cohorts and the adjudication of cardiovascular disease outcomes.

In the last seven years, Dr Barr has published a book chapter and 22 peer-reviewed journal articles. She has published in prestigious journals in the fields of general medicine, cardiovascular disease and diabetes, including a publication in each of the New England Journal of Medicine and the British Medical Journal, two publications in Circulation, four in Diabetes Care and three in Diabetologia. Her work has been cited 787 times, and she has an overall H Index of 13. Dr Barr has presented at both national and international meetings and has published 21 conference abstracts. Dr Barr has obtained A$307,000 in competitive research grants and scholarship funding. 

Research Themes
  • DRUID follow-up study
  • Australian, diabetes obesity and lifestyle study (AusDiab)
  • A comparison of trends of type 2 diabetes mellitus prevalence in Singapore, Mauritius and China.
  1. Barr, E. L. M., Wong, T. Y., Tapp, R. J., Harper, C .A., Zimmet, P. Z., Atkins, R., et al., on behalf of the AusDiab Steering Committee. (2006). Is Peripheral Neuropathy Associated with Retinopathy and Albuminuria in Individuals with Impaired Glucose Metabolism? The 1999–2000 AusDiab Study. Diabetes Care, 29(5), 1114-1116.
  2. Barr, E. L. M., Zimmet, P. Z., Welborn, T. A., Jolley, D., Magliano, D.J., Dunstan, D. W., et al. (2007). Risk of cardiovascular and all-cause mortality in individuals with diabetes, impaired fasting glucose and impaired glucose tolerance: the AusDiab study. Circulation, 116(2), 151-157.
  3. Al Salmi, I., Hoy, W.E., Kondalsamy-Chennakesavan, S., Wang, Z., Gobe, G. C., Barr, E. L. M., et al. (2008). Disorders of glucose regulation in adults and birth weight. Diabetes Care, 31(1), 159–164.
  4. Boyko, E. J., Barr, E. L. M., Zimmet, P. Z., & Shaw, J. E. (2008). Two-hour glucose predicts the development of hypertension over 5 years: the AusDiab study. Journal of Human Hypertension, 22(3), 168-176.
  5. Magliano, D. J., Barr, E. L. M., Zimmet, P. Z., Cameron, A. J., Dunstan, D. W., Colagiuri, S., et al. (2008). Glucose indices, health behaviours and incidence of diabetes in Australia. Diabetes Care, 31(2), 267-272.
  6. Barr, E. L. M., Boyko, E. J., Zimmet, P. Z., Wolfe, R., Tonkin, A. M., & Shaw, J. E. (2009). Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia, 52(3), 415-424.
  7. Barr, E. L. M., Cameron, A. J., Balkau, B., Zimmet, P. Z., Welborn, T. A., Tonkin, A. M., et al. (2010). HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetologia, 53(1), 79-88.
  8. Dunstan, D.W., Barr, E. L. M., Healy, G. N., Salmon,  J., Shaw, J. E., Balkau, B., et al. (2010). Television Viewing Time and Mortality: The Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Circulation, 121(3), 384-391.
  9. Dwyer, T., Ponsonby, A-L., Ukoumunne, O.C., Pezic, A., Venn, A., Dunstan, D., Barr, E. L. M., et al. (2011). Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study. British Medical Journal, 342, c7249.
  10. Emerging Risk Factors Collaboration, et al. (2012). C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine, 367(4), 1310-20.
  1. Jessica Mauboy sings out to end Indigenous diabetes and heart disease epidemic

    Jessica Mauboy sings out to end Indigenous diabetes and heart disease epidemic

    Date

    Singer Jessica Mauboy is calling for Darwin-based Aboriginal and Torres Strait Islander people to complete a quick survey as part of the Diabetes and Related Conditions in Urban Indigenous People in the Darwin Region (DRUID) study, a ground-breaking diabetes and heart disease study.